entity

cell_type

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about cell_type: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
5Hypotheses
20Analyses
1Outgoing
1Incoming

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Corticobasal Syndrome (CBS)

disease · 11374 words

Outgoing (1)

TargetRelationTypeStr
Transcriptomecorrelates_withprocess0.85

Incoming (1)

SourceRelationTypeStr
GPR37expressed_inprotein0.95

Targeting Hypotheses (5)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-S 0.576 neurodegeneration What are the cell-type-specific transcri
Cell-Type Specific TREM2 Upregulation in DAM Microglia 0.519 Alzheimer's Disease SEA-AD Gene Expression Profiling — Allen
Cell-Type Specific TFEB Modulation 0.482 neurodegeneration Does TFEB dysfunction cause neurodegener
Cell-Type Specific Metabolic Reprogramming 0.471 neurodegeneration Cell type vulnerability in Alzheimers Di
Cross-Cell Type Synaptic Rescue via Tripartite Synapse Resto 0.454 neurodegeneration Cell type vulnerability in Alzheimer's D

Mentioning Analyses (20)

Scientific analyses that reference this entity

How do oligodendrocytes initiate neuroinflammation in PD when microglia are trad

neuroinflammation | 2026-04-13 | 2 hypotheses Top: 0.632

Which specific cell types show greatest vulnerability in AD based on SEA-AD tran

neurodegeneration | 2026-04-11 | 0 hypotheses

Which neural cell types exhibit the most pronounced gene expression alterations

neurodegeneration | 2026-04-11 | 0 hypotheses

Can circadian interventions selectively target microglia without affecting other

neuropharmacology | 2026-04-10 | 0 hypotheses

What determines the specificity of TDP-43-induced mitochondrial DNA release for

neurodegeneration | 2026-04-07 | 0 hypotheses

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] Zhou Y, Song WM, Andhey PS, Swain A, Lev Nat Med 2020 1
Chemical and Molecular Strategies in Restoring Autophagic Flux in TDP-43 Protein [PMID:41900026] Jamerlan A, Hulme J Molecules (Basel, Switzerland) 2026 0
Mammalian lipophagy: process and function. [PMID:41681129] Zhao R, Dai E, Kang R, Liu J, Klionsky D Autophagy 2026 0
Electroacupuncture regulates neuronal ferroptosis and ferritinophagy through lys [PMID:41272418] Tang B, Xu X, Zhao W, Zhou Q, Du G et al J Cereb Blood Flow Metab 2026 0
Endothelial Transcription Factor EB Protects Against Doxorubicin-Induced Endothe [PMID:41410033] Du W, Ringer M, Desai D, Khandakar GI, T Circulation 2026 0
Proteotoxic stress triggers TFEB- and TFE3-mediated autophagy and lysosomal biog [PMID:41450115] Zhu Z, Yang J, Montefusco S, Xia S, Ou J Autophagy 2026 0
Microglia TFEB activation attenuates Alzheimer's disease pathology by enhancing [PMID:41673711] Kim Y, Ha TY, Kondaurova O, Lee MS, Chan J Neuroinflammation 2026 0
TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and [PMID:41899560] Portu M, Balsa M, Cotaina M, Anguera G, Cancers (Basel) 2026 0
Transcription Factor EB Drives Thrombospondin-1 Expression to Dampen Focal-adhes [PMID:41935359] Liu C, Zhang Q, Zhou D, Li B, Cheng J et Curr Gene Ther 2026 0
Modulation of the AMPK/TFEB Axis by Ezetimibe Attenuates Neuroinflammatory, Oxid [PMID:41944914] Aditi, Wani SN, Akanksha, Kumar A, Singh Journal of neuroimmune pharmac 2026 0
TFEB has a protective effect in cisplatin induced AKI through regulating exosome [PMID:41946126] Xu Z, Xiang H, Liu H, Zhang C, Zhang X e Int Immunopharmacol 2026 0
Cabozantinib activates TFEB-mediated autophagy to exert anti-tumor effects in he [PMID:41951909] Chen C, Hu Y, Zhang C, Zhou X In Vitro Cell Dev Biol Anim 2026 0
NIBV Induces Incomplete Autophagy via AMPK-TFEB, Causing Kidney Injury in Chicks [PMID:41955488] Huang C, Zeng Y, Chen Y, Li Z, Omar SM e Adv Sci (Weinh) 2026 0
Lysosomal homeostasis at the crossroads of neurodegeneration. [PMID:41919495] De Tito S, Tooze SA The Journal of clinical invest 2026 0
Targeting microglial inflammation in Parkinson's disease: irisin activates PAFAH [PMID:41520051] Cai L, Liu Y, Tang S, Deng S, Zhang L, W Communications biology 2026 0
Organelle dysfunction and TNT-mediated aggregate spreading in neurodegeneration. [PMID:41543365] Thomas V, Zurzolo C Physiology (Bethesda, Md.) 2026 0
Moderate Effects of the Arginine to Histidine R47H Variant of the Triggering Rec [PMID:41890852] ["Ramirez G", "Hernandez D", "Teal A", " Research square 2026 0
Increased plasma soluble TREM2 levels in non-Alzheimer's dementia. [PMID:41920402] Güven G, Gezegen H, Şahin E, Samancı B, Acta neurologica Belgica 2026 0
AI-guided design of cyclic peptide binders targeting TREM2 using CycleRFdiffusio [PMID:41435973] Cho S, Zhu R, Kuncewicz K, Duan H, Gabr Bioorg Med Chem Lett 2026 0
ITAM-Syk signaling mediates the rebound phenomenon after anti-RANKL antibody dis [PMID:41490759] Ishizu H, Hasegawa T, Shimizu T, Yamamot Bone 2026 0